refractory lymphoma

Related by string. * Refractory : relapsed refractory multiple myeloma . refractory Hodgkin lymphoma . hormone refractory prostate cancer . relapsed refractory AML . refractory anemia . rituximab refractory follicular / Lymphomas . lymphomas . LYMPHOMA . Lymphoma : cure leukemia lymphoma . Cure leukemia lymphoma . anaplastic lymphoma kinase ALK . Hodgkin lymphoma HL . leukemia lymphoma * *

Related by context. Frequent words. (Click for all words.) 61 refractory multiple myeloma 60 relapsed refractory multiple myeloma 58 medullary thyroid cancer 58 metastatic renal cell carcinoma 58 lymphoma CTCL 57 refractory Hodgkin lymphoma 57 chronic HCV 57 IV melanoma 56 diagnosed multiple myeloma 56 hepatitis C HCV 56 relapsed refractory 56 B CLL 55 relapsed multiple myeloma 55 gastrointestinal stromal tumors 55 acute myelogenous leukemia AML 55 axitinib 55 Nimotuzumab 54 advanced NSCLC 54 glioblastoma multiforme GBM 54 imatinib mesylate 54 HER2 positive metastatic breast 54 TREANDA 54 phase IIa 53 cutaneous T cell 53 CTCL 53 HCV infection 53 vandetanib 53 Jevtana 53 Alemtuzumab 53 thymalfasin 53 chronic myelogenous leukemia CML 53 Laquinimod 52 castration resistant prostate cancer 52 chronic lymphocytic leukemia CLL 52 myelodysplastic syndrome MDS 52 Torisel 52 IMGN# 52 biologic therapy 52 androgen independent 52 Advexin 52 AP# [003] 52 dacarbazine 52 registrational 52 hepatocellular carcinoma HCC 52 cell chronic lymphocytic 52 bone metastasis 51 valopicitabine 51 chronic myeloid leukemia CML 51 neoplasm 51 COPAXONE ® 51 vinorelbine 51 diabetic neuropathic pain 51 Reolysin 51 anti TNF alpha 51 lupus nephritis 51 refractory PTCL 51 tanespimycin 51 romidepsin 51 hepatocellular carcinoma 51 Folotyn 51 azacitidine 51 interferon alfa 51 Phase 1b clinical 51 LIALDA 51 plus gemcitabine 51 Phase IIa trial 51 systemic lupus erythematosus 50 TYKERB 50 renal cell carcinoma 50 BAY #-# 50 systemic lupus 50 romiplostim 50 metastatic colorectal cancer 50 Bortezomib 50 HRPC 50 unresectable 50 chronic angina 50 liver metastases 50 peg IFN 50 PegIntron 50 evaluable 50 FOLFIRI 50 Taxotere ® 50 metastatic colon cancer 50 Chronic Lymphocytic Leukemia 50 hematologic malignancies 50 HGS ETR1 50 myelofibrosis 50 Mylotarg 50 azathioprine 50 Acute Myeloid Leukemia AML 50 L Annamycin 50 adalimumab 50 ADXS# 50 NSCLC 50 temsirolimus 50 IIa clinical trial 50 relapsing remitting multiple sclerosis 50 Erlotinib 50 antiepileptic drug 50 INCB# [002]

Back to home page